IONIS PHARMACEUTICALS's ticker is IONS and the CUSIP is 462222100. A total of 42 filers reported holding IONIS PHARMACEUTICALS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $171,691 | -24.9% | 4,701,297 | -23.8% | 1.02% | +6.4% |
| Q1 2022 | $228,585 | +6.1% | 6,171,308 | -12.9% | 0.95% | +46.3% |
| Q4 2021 | $215,543 | -24.5% | 7,083,256 | -16.8% | 0.65% | -5.0% |
| Q3 2021 | $285,472 | -19.7% | 8,511,384 | -4.4% | 0.69% | +3.8% |
| Q2 2021 | $355,329 | +53.7% | 8,907,733 | +73.2% | 0.66% | +44.0% |
| Q1 2021 | $231,197 | +70.4% | 5,142,271 | +114.3% | 0.46% | +27.1% |
| Q4 2020 | $135,671 | +468.9% | 2,399,554 | +377.5% | 0.36% | +156.0% |
| Q3 2020 | $23,846 | +17.5% | 502,560 | +46.0% | 0.14% | -35.3% |
| Q2 2020 | $20,290 | +258.5% | 344,131 | +187.5% | 0.22% | +54.6% |
| Q1 2020 | $5,659 | -56.6% | 119,681 | -44.6% | 0.14% | -57.1% |
| Q4 2019 | $13,050 | +10.8% | 216,025 | +9.8% | 0.33% | +28.0% |
| Q3 2019 | $11,782 | +16.2% | 196,669 | +24.7% | 0.26% | +0.8% |
| Q2 2019 | $10,140 | -24.3% | 157,773 | -4.4% | 0.26% | -33.4% |
| Q1 2019 | $13,391 | +2.2% | 164,978 | -31.9% | 0.38% | -28.0% |
| Q4 2018 | $13,099 | +10.7% | 242,312 | +5.7% | 0.53% | +49.0% |
| Q3 2018 | $11,828 | +33.2% | 229,318 | +7.6% | 0.36% | +9.8% |
| Q2 2018 | $8,881 | -42.7% | 213,127 | -39.4% | 0.32% | -57.8% |
| Q1 2018 | $15,512 | -16.8% | 351,905 | -5.1% | 0.77% | -48.2% |
| Q4 2017 | $18,653 | +107.2% | 370,835 | +109.5% | 1.49% | -15.2% |
| Q2 2017 | $9,004 | +75.6% | 176,991 | +38.7% | 1.75% | +18.6% |
| Q1 2017 | $5,128 | +1517.7% | 127,563 | +1826.6% | 1.48% | +1185.2% |
| Q4 2016 | $317 | – | 6,621 | – | 0.12% | – |
Download | ||||||